生物
癌变
小RNA
癌症研究
基因敲除
癌基因
下调和上调
乳腺癌
转染
细胞生长
细胞
分子生物学
基因
癌症
细胞周期
遗传学
作者
Min-Liang Si,Shengtao Zhu,Hui Wu,Zhongxin Lu,Feng Wu,Y-Y Mo
出处
期刊:Oncogene
[Springer Nature]
日期:2006-10-30
卷期号:26 (19): 2799-2803
被引量:1551
标识
DOI:10.1038/sj.onc.1210083
摘要
MicroRNAs (miRNAs) are ∼22 nucleotide non-coding RNA molecules that regulate gene expression post-transcriptionally. Although aberrant expression of miRNAs in various human cancers suggests a role for miRNAs in tumorigenesis, it remains largely unclear as to whether knockdown of a specific miRNA affects tumor growth. In this study, we profiled miRNA expression in matched normal breast tissue and breast tumor tissues by TaqMan real-time polymerase chain reaction miRNA array methods. Consistent with previous findings, we found that miR-21 was highly overexpressed in breast tumors compared to the matched normal breast tissues among 157 human miRNAs analysed. To better evaluate the role of miR-21 in tumorigenesis, we transfected breast cancer MCF-7 cells with anti-miR-21 oligonucleotides and found that anti-miR-21 suppressed both cell growth in vitro and tumor growth in the xenograft mouse model. Furthermore, this anti-miR-21-mediated cell growth inhibition was associated with increased apoptosis and decreased cell proliferation, which could be in part owing to downregulation of the antiapoptotic Bcl-2 in anti-miR-21-treated tumor cells. Together, these results suggest that miR-21 functions as an oncogene and modulates tumorigenesis through regulation of genes such as bcl-2 and thus, it may serve as a novel therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI